Complement Component C1: Key Protein in Immune System (P10263)

Target Name: Complement component C1

NCBI ID: P10263

Complement component C1

Other Name(s): None

Complement Component C1: Key Protein in Immune System

Complement component C1, also known as CR2, is a protein that is found in the blood plasma of human beings. It is a part of the complement system, which is a group of proteins that work together to help the immune system fight off infections. C1 is a key component of the complement system, and it plays a crucial role in protecting the body against bacterial and viral infections.

The complement system works by attaching to the surface of an invading microbe or virus, allowing the immune system to recognize and destroy it. C1 helps to facilitate this process by forming a complex with the microbe or virus, allowing the immune system to recognize it and initiate an attack.

C1 is a large protein that is made up of several subunits. It is made up of a tail that is responsible for helping it to stick to the surface of an invading microbe or virus, as well as a series of other regions that give it its unique structure and function.

One of the key functions of C1 is its ability to form a complex with invading microbes and viruses. This complex is called a \"complement complex,\" and it allows the immune system to recognize and destroy the microbe or virus more efficiently.

C1 is also involved in the regulation of the complement system. It helps to ensure that the complement system is activated and ready to respond to the presence of an invading microbe or virus. It also helps to ensure that the complement complex is formed correctly, which is critical for effective immune response.

C1 is a drug target (or biomarker) because it is a key protein that is involved in the immune system. Researchers are interested in studying C1 because they hope to develop new treatments for bacterial and viral infections. By targeting C1 with drugs, researchers hope to inhibit its function and prevent the formation of complement complexes, which could lead to the destruction of invading microbes and viruses.

Complement component C1 has also been identified as a potential biomarker for monitoring the effectiveness of cancer treatments. Because C1 is involved in the immune system, researchers hope to use it as a marker to track the progress of cancer treatments. By measuring the levels of C1 in the blood after cancer treatment, researchers hope to get a sense of how effective the treatment is.

Conclusion

Complement component C1 is a protein that is found in the blood plasma of human beings. It is a key component of the complement system, and it plays a crucial role in protecting the body against bacterial and viral infections. C1 is also a drug target (or biomarker) because it is involved in the immune system, and it has been identified as a potential biomarker for monitoring the effectiveness of cancer treatments. Researchers are continuing to study C1 in order to better understand its function and potential as a drug.

Protein Name: Complement Component C1

The "Complement component C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Complement component C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets